CHROMADEX CORPORATION

Analyst Reco. ChromaDex Corporation

Equities

CDXC

US1710774076

Market Closed - Nasdaq Other stock markets 21:00:00 09/05/2024 BST			5-day change	1st Jan Change
3.52 ^USD	-8.09%		-6.38%	+146.15%

05-08	Transcript : ChromaDex Corporation, Q1 2024 Earnings Call, May 08, 2024
05-08	Earnings Flash (CDXC) CHROMADEX CORPORATION Reports Q1 Revenue $22.2M, vs. Street Est of $23.6M	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Roth MKM Raises Price Target on ChromaDex to $6 From $4.25, Keeps Buy Rating	04-09	MT
HC Wainwright Adjusts Price Target on ChromaDex to $6 From $5, Maintains Buy Rating	03-11	MT
HC Wainwright Adjusts Price Target on ChromaDex to $5 From $5.50, Keeps Buy Rating	13/03/23	MT
B. Riley Trims ChromaDex's Price Target to $2 From $2.10 After Mixed Q4 Metrics, Keeps Neutral Rating	09/03/23	MT
HC Wainwright Adjusts Price Target on ChromaDex to $5.50 From $7, Reiterates Buy Rating	29/08/22	MT
Oppenheimer Downgrades ChromaDex to Perform From Outperform, Removes $7 Price Target	16/08/22	MT
Roth Capital Adjusts ChromaDex Price Target to $4.25 From $5.75, Maintains Buy Rating	11/08/22	MT
B. Riley Downgrades ChromaDex to Neutral from Buy, Notes Reduced 2022 Revenue Guidance, Lowers PT to $2.40 from $6	11/08/22	MT
HC Wainwright Adjusts Price Target on ChromaDex to $7 From $8, Reiterates Buy Rating	07/06/22	MT
B. Riley Lowers ChromaDex's Price Target to $6 from $8 on Lower Multiple, Keeps Buy Rating	13/05/22	MT
HC Wainwright Adjusts ChromaDex's Price Target to $8 From $12, Keeps Buy Rating	18/04/22	MT
B. Riley Lowers ChromaDex's Price Target to $8 from $16 After Q4 Sales Miss Estimates, Maintains Buy Rating	10/03/22	MT
Roth Capital Starts ChromaDex at Buy With $7 Price Target	08/03/22	MT
CHROMADEX : B. Riley Lowers ChromaDex's PT to $16 from $18 After 'Roughly In Line' Q2 Metrics, Keeps Buy Rating	04/08/21	MT
CHROMADEX : HC Wainwright Adjusts ChromaDex PT to $11 From $16, Maintains Buy Rating	10/05/21	MT
CHROMADEX : HC Wainwright Adjusts Price Target on ChromaDex to $16 From $7, Maintains Buy Rating	16/03/21	MT
CHROMADEX : Oppenheimer Adjusts ChromaDex PT to $17 From $9, Maintains Outperform Rating	12/03/21	MT
CHROMADEX : B. Riley Raises ChromaDex' Price Target to $18 from $7, Expects Roughly in-Line Q4 2020 Results; Keeps Buy Rating	09/03/21	MT
CHROMADEX : B Riley Raises ChromaDex' Price Target to $18 from $7, Cites Favorable Clinical Studies Reflecting Potentially Broad Relevance; Keeps Buy Rating	08/03/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer